🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Worapol Ngamcherdtrakul

PDX Pharmaceuticals (United States)

ORCID: 0000-0003-4187-7709
MedicineImmunology and MicrobiologyEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: Development of novel immunotherapy based on nanoparticle co-delivering PLK1 and PD-L1 inhibitors for lung cancer treatment.

2 citations

Worapol Ngamcherdtrakul, Natnaree Siriwon, Daniel S. Bejan, Sherif M. Reda, Ruijie Wang +8 more

191 citations

Worapol Ngamcherdtrakul, Molly A. Nelson, Natnaree Siriwon, Ruijie Wang, Husam Y. Zaidan +10 more

48 citations

Daniel S. Bejan, William Cruz‐Muñoz, Moataz Reda, Husam Y. Zaidan, Natnaree Siriwon +8 more

0 citations

Worapol Ngamcherdtrakul, Molly A. Nelson, Natnaree Siriwon, Ruijie Wang, Husam Y. Zaidan +10 more

25 citations

Pramod Kumar, Moataz Reda, Alyssa Wallstrum, Noah Crumrine, Worapol Ngamcherdtrakul +2 more